Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,506 | 88,481 | 104,641 | 104,161 | 61,900 |
| Marketable Securities | 2,448 | 2,787 | 2,543 | 6,896 | 21,038 |
| Other current assets | 2,025 | 1,464 | 1,890 | 1,488 | 1,451 |
| TOTAL | $66,825 | $113,486 | $140,577 | $143,092 | $114,990 |
| Non-Current Assets | |||||
| PPE Net | 151,487 | 154,165 | 143,659 | 130,441 | 119,445 |
| Investments And Advances | 841 | 820 | 840 | 811 | 914 |
| Intangibles | 18,992 | 19,502 | 20,003 | 20,471 | 21,738 |
| Other Non-Current Assets | 53,082 | 55,427 | 57,277 | 58,128 | 60,630 |
| TOTAL | $224,402 | $229,914 | $221,779 | $209,851 | $202,727 |
| Total Assets | $291,227 | $343,400 | $362,356 | $352,943 | $317,717 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 481,894 | 471,478 | 431,901 | N/A | N/A |
| Accounts payable and accrued liabilities | 26,647 | 36,505 | 24,485 | 23,255 | 22,211 |
| Accrued Expenses | 62,335 | 54,118 | 41,825 | 46,220 | 52,351 |
| TOTAL | $613,478 | $564,945 | $500,861 | $70,840 | $376,050 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | N/A | 373,293 | 312,541 |
| Other Non-Current Liabilities | 323,266 | 310,411 | 311,426 | 338,114 | 51,185 |
| TOTAL | $322,932 | $310,171 | $311,315 | $711,184 | $363,641 |
| Total Liabilities | $936,410 | $875,116 | $812,176 | $782,024 | $739,691 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 456,247 | 435,985 | 435,836 | 400,304 | 400,304 |
| Common Shares | 44 | 43 | 42 | 40 | 40 |
| Retained earnings | -2,632,710 | -2,494,831 | -2,378,488 | -2,270,273 | -2,159,335 |
| Other shareholders' equity | -3,107 | -2,766 | -2,310 | -2,572 | -2,269 |
| TOTAL | $-645,183 | $-531,716 | $-449,820 | $-429,081 | $-421,974 |
| Total Liabilities And Equity | $291,227 | $343,400 | $362,356 | $352,943 | $317,717 |